⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JAGX News
Jaguar Health, Inc.
Form 8-K
sec.gov
JAGX
Form 8-K
sec.gov
JAGX
Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health
accessnewswire.com
JAGX
Martinrea International Inc. Reports First Quarter Results and Declares Dividend
globenewswire.com
GM
F
VOW3.DE
MBG.DE
JAGX
TSLA
NVDA
GOOG
AMZN
MSFT
Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
accessnewswire.com
JAGX
Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
accessnewswire.com
JAGX